XML 15 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating activities    
Net loss $ (5,427,661) $ (4,243,118)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 16,627 14,168
Stock-based compensation 421,285 373,947
Non-cash interest on convertible notes 51,333 159,918
Non-cash discount amortization on short-term notes and convertible notes 233,224 675,632
Revaluation of premium conversion derivatives 111,195 (459,791)
Revaluation of warrant liability 18,568 286,747
Loss on note extinguishments, net 553,447 537,134
Change in assets and liabilities:    
Prepaid expenses (46,502) 6,527
Accounts payable and accrued expenses (184,555) 755,573
Net cash used in operating activities (4,253,039) (1,893,263)
Investing activities    
Purchase of intangible assets (65,000) (146,709)
Purchase of property and equipment (53,952)
Net cash used in investing activities (118,952) (146,709)
Financing activities    
Proceeds from issuance of convertible promissory notes 761,278
Proceeds from issuance of warrants associated with convertible notes 778,722
Issuance costs related to convertible notes (9,779)
Issuance costs related to warrants (8,670)
Proceeds from issuance of common stock in connection with private placement 4,476,583
Proceeds from issuance of warrants in connection with private placement 1,678,865
Issuance costs in connection with private placement (689,494)
Exercise of warrants 416,333
Exercise of stock-options 6,250
Proceeds from unsecured loans 245,000 283,000
Advances 188,000
Repayment of unsecured loans (528,000)
Net cash provided by financing activities 5,605,537 1,992,551
Net increase (decrease) in cash 1,233,546 (47,421)
Cash at beginning of period 13,260 70,029
Cash at end of period 1,246,806 22,608
Supplemental non-cash financing and investing transactions:    
Conversion of convertible promissory notes to equity 1,678,361
Exercise of premium conversion derivative liability 419,590
Reclassification of warrant liability to equity 835,723
Bifurcation of premium conversion derivative related to convertible notes 296,909
Issuance of warrants in connection with convertible notes 117,280
Stock value adjustment associated with intellectual license agreement 299
Change in accounts payable and accrued expenses attributed to private placement and convertible note issuance costs 257,941 17,076
Purchased intangible assets in accrued expenses 30,000
Stock-based compensation liability reclassification to equity $ 11,153